ARESTIN: payments to doctors
Payments that named ARESTIN as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.2M
- Providers
- 25,014
- Transactions
- 59,525
- Average per transaction
- $54
The per-transaction average — $54 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 25,014 providers the average total is $129, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Orapharma, A Division Of Bausch Health US, LLC | $3,235,128 | 100.0% |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | $234 | 0.0% |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | $187 | 0.0% |